These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18172353)
1. [Pathogenesis and treatment of intestinal Behçet's disease]. Lee CK; Kim HJ Korean J Gastroenterol; 2007 Jul; 50(1):3-8. PubMed ID: 18172353 [TBL] [Abstract][Full Text] [Related]
2. Update on the Medical Management of Gastrointestinal Behçet's Disease. Lopalco G; Rigante D; Venerito V; Fabiani C; Franceschini R; Barone M; Lapadula G; Galeazzi M; Frediani B; Iannone F; Cantarini L Mediators Inflamm; 2017; 2017():1460491. PubMed ID: 28210071 [TBL] [Abstract][Full Text] [Related]
3. Behçet's syndrome: from aetiology to treatment. Powell RJ Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749 [No Abstract] [Full Text] [Related]
5. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease. Sayarlioglu M; Kotan MC; Topcu N; Bayram I; Arslanturk H; Gul A Ann Pharmacother; 2004 May; 38(5):808-11. PubMed ID: 15010523 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report. Hassard PV; Binder SW; Nelson V; Vasiliauskas EA Gastroenterology; 2001 Mar; 120(4):995-9. PubMed ID: 11231954 [TBL] [Abstract][Full Text] [Related]
7. A case of Behçet's disease with various gastrointestinal findings. Tominaga K; Kamimura K; Takahashi K; Yokoyama J; Terai S Clin J Gastroenterol; 2018 Oct; 11(5):354-358. PubMed ID: 29667077 [TBL] [Abstract][Full Text] [Related]
8. Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature. Toyonaga T; Nakase H; Matsuura M; Minami N; Yamada S; Honzawa Y; Hukata N; Yoshino T; Chiba T; Okazaki K Digestion; 2013; 88(4):217-21. PubMed ID: 24247154 [TBL] [Abstract][Full Text] [Related]
14. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis? Kim DH; Cheon JH Yonsei Med J; 2016 Jan; 57(1):22-32. PubMed ID: 26632379 [TBL] [Abstract][Full Text] [Related]
15. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients. Tsai J; Chen GS; Lu YW; Wu CS; Lan CC J Eur Acad Dermatol Venereol; 2008 May; 22(5):596-600. PubMed ID: 18266686 [TBL] [Abstract][Full Text] [Related]
16. Etiopathogenesis of Behcet's disease. Mendoza-Pinto C; García-Carrasco M; Jiménez-Hernández M; Jiménez Hernández C; Riebeling-Navarro C; Nava Zavala A; Vera Recabarren M; Espinosa G; Jara Quezada J; Cervera R Autoimmun Rev; 2010 Feb; 9(4):241-5. PubMed ID: 19879978 [TBL] [Abstract][Full Text] [Related]
17. Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease. Behrens F; Zollner T; Moeller B; Kaltwasser JP; Kaufmann R; Ochsendorf FR Adv Exp Med Biol; 2003; 528():561-2. PubMed ID: 12918764 [No Abstract] [Full Text] [Related]
18. Managing the symptoms of Behçet's disease. Evereklioglu C Expert Opin Pharmacother; 2004 Feb; 5(2):317-28. PubMed ID: 14996628 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody]. Asakura H Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969 [TBL] [Abstract][Full Text] [Related]
20. Behçet's disease: New insights into pathophysiology, clinical features and treatment options. Greco A; De Virgilio A; Ralli M; Ciofalo A; Mancini P; Attanasio G; de Vincentiis M; Lambiase A Autoimmun Rev; 2018 Jun; 17(6):567-575. PubMed ID: 29631062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]